253 related articles for article (PubMed ID: 16606962)
1. Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.
Yuan G; Wang J; Hegele RA
CMAJ; 2006 Apr; 174(8):1124-9. PubMed ID: 16606962
[TBL] [Abstract][Full Text] [Related]
2. Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.
Viladés Medel D; Leta Petracca R; Carreras Costa F; Cardona Olle M; Barros Membrilla A; Hidalgo Perez JA; Pujadas Olano S; Alomar Serrallach X; Franco Peral M; Pons-Lladó G
Am J Cardiol; 2013 Apr; 111(7):955-61. PubMed ID: 23340035
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
Cao YX; Zhou BY; Sun D; Li S; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Liu G; Dong Q; Li JJ
Per Med; 2019 Nov; 16(6):467-478. PubMed ID: 31691639
[No Abstract] [Full Text] [Related]
5. The detection of heterozygous familial hypercholesterolemia in Ireland.
O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C
Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724
[TBL] [Abstract][Full Text] [Related]
6. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden.
Rallidis LS; Kosmas N; Tsirebolos G; Rallidi M; Kiouri E; Kalpakos D
J Clin Lipidol; 2019; 13(3):502-508. PubMed ID: 30956097
[TBL] [Abstract][Full Text] [Related]
8. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
9. [Heterozygous familial hypercholesterolemia].
Özcan ÖU; Güleç S
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():10-8. PubMed ID: 25693359
[TBL] [Abstract][Full Text] [Related]
10. [Heterozygous familial hypercholesterolemia: the first challenge for anti-PCSK9 monoclonal antibodies].
Zambon A
G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):22S-30. PubMed ID: 27312020
[TBL] [Abstract][Full Text] [Related]
11. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
[TBL] [Abstract][Full Text] [Related]
12. Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S; Sánchez-Hernández RM; Plana N; Marco-Benedi V; Pedro-Botet J; Almagro F; Brea A; Ascaso JF; Lahoz C; Civeira F;
Am J Cardiol; 2017 Mar; 119(5):742-748. PubMed ID: 28081939
[TBL] [Abstract][Full Text] [Related]
13. Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.
Arca M
Atherosclerosis; 2017 Jan; 256():134-145. PubMed ID: 27993383
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
Marquina C; Morton J; Brett T; Lloyd M; Radford J; Heal C; Hespe C; Gill G; Sullivan D; Zomer E; Li I; Pang J; Watts GF; Ademi Z
Circ Genom Precis Med; 2023 Jun; 16(3):267-274. PubMed ID: 37042242
[TBL] [Abstract][Full Text] [Related]
15. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle.
Shek A; Alieva R; Kurbanov R; Hoshimov S; Nizamov U; Abdullaeva G; Nagay A
Atherosclerosis; 2018 Oct; 277():524-529. PubMed ID: 30270094
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
[TBL] [Abstract][Full Text] [Related]
17. Maternally inherited hypercholesterolemia does not modify the cardiovascular phenotype in familial hypercholesterolemia.
Marco-Benedí V; Laclaustra M; Bea AM; Suarez-Tembra M; Plana N; Pinto X; Brea A; Sanchez-Hernandez RM; Civeira F
Atherosclerosis; 2021 Mar; 320():47-52. PubMed ID: 33529866
[TBL] [Abstract][Full Text] [Related]
18. Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.
Corral P; Aguilar Salinas CA; Matta MG; Zago V; Schreier L
Curr Atheroscler Rep; 2023 Dec; 25(12):899-909. PubMed ID: 37921916
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects.
Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD
J Am Coll Cardiol; 2014 Jun; 63(22):2365-73. PubMed ID: 24632287
[TBL] [Abstract][Full Text] [Related]
20. Current causes of death in familial hypercholesterolemia.
Marco-Benedí V; Bea AM; Cenarro A; Jarauta E; Laclaustra M; Civeira F
Lipids Health Dis; 2022 Aug; 21(1):64. PubMed ID: 35918701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]